Evaluation of BRAF Gene Status in Gliomas

Neurology and Neurobiology Pub Date : 2021-08-16 DOI:10.31487/j.nnb.2021.03.02

A. Jaiswal, S. Agrawal, S. Jaiswal, K. Das, S. Behari, S. Tewari, Madam Mohan Godbole, P. Misra

{"title":"Evaluation of BRAF Gene Status in Gliomas","authors":"A. Jaiswal, S. Agrawal, S. Jaiswal, K. Das, S. Behari, S. Tewari, Madam Mohan Godbole, P. Misra","doi":"10.31487/j.nnb.2021.03.02","DOIUrl":null,"url":null,"abstract":"Background: Development of different molecular markers has given a new insight in the glioma \nmanagement. KIAA1549-BRAF gene fusion has a diagnostic and prognostic significance. \nAim: The aim of this study was to determine the KIAA1549-BRAF gene fusion in glioma and their \ncorrelation with various clinical parameters.\nMaterial and Methods: Forty cases of glioma were studied for KIAA1549-BRAF gene fusion by reverse \ntranscription-PCR (RT-PCR).\nResults: Overall, KIAA1549-BRAF gene fusion was found in 22% (9/40) cases of glioma. Children had \nhigher KIAA1549-BRAF fusion (72%; 8/11) as compared to adults (10%; 3/29) and this difference was \nstatistically significant. Cerebellar location of tumor was significantly associated with KIAA1549-BRAF\nfusion. KIAA1549-BRAF fusion was highest in pilocytic astrocytoma (89%), and this difference was \nstatistically significant. Statistically significant difference was noted between KIAA1549-BRAF fusion \nexpression and WHO grade I glioma. \nConclusion: Overall, KIAA1549-BRAF gene fusion was found in 22% (9/40) cases of glioma. Childhood \nage, pilocytic astrocytoma histology, cerebellar location and WHO grade I tumor were significantly \nassociated with KIAA1549-BRAF gene fusion.","PeriodicalId":19179,"journal":{"name":"Neurology and Neurobiology","volume":"17 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology and Neurobiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31487/j.nnb.2021.03.02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Development of different molecular markers has given a new insight in the glioma management. KIAA1549-BRAF gene fusion has a diagnostic and prognostic significance. Aim: The aim of this study was to determine the KIAA1549-BRAF gene fusion in glioma and their correlation with various clinical parameters. Material and Methods: Forty cases of glioma were studied for KIAA1549-BRAF gene fusion by reverse transcription-PCR (RT-PCR). Results: Overall, KIAA1549-BRAF gene fusion was found in 22% (9/40) cases of glioma. Children had higher KIAA1549-BRAF fusion (72%; 8/11) as compared to adults (10%; 3/29) and this difference was statistically significant. Cerebellar location of tumor was significantly associated with KIAA1549-BRAF fusion. KIAA1549-BRAF fusion was highest in pilocytic astrocytoma (89%), and this difference was statistically significant. Statistically significant difference was noted between KIAA1549-BRAF fusion expression and WHO grade I glioma. Conclusion: Overall, KIAA1549-BRAF gene fusion was found in 22% (9/40) cases of glioma. Childhood age, pilocytic astrocytoma histology, cerebellar location and WHO grade I tumor were significantly associated with KIAA1549-BRAF gene fusion.

查看原文本刊更多论文

脑胶质瘤中BRAF基因状态的评估

背景:不同分子标记的发展为胶质瘤的治疗提供了新的视角。KIAA1549-BRAF基因融合具有诊断和预后意义。目的:本研究的目的是确定KIAA1549-BRAF基因在胶质瘤中的融合及其与各种临床参数的相关性。材料与方法:采用逆转录- pcr (RT-PCR)对40例胶质瘤患者进行KIAA1549-BRAF基因融合研究。结果:总体而言，在22%(9/40)的胶质瘤病例中发现KIAA1549-BRAF基因融合。儿童KIAA1549-BRAF融合率较高(72%;8/11)，与成人相比(10%;3/29)，差异有统计学意义。小脑肿瘤位置与KIAA1549-BRAFfusion显著相关。KIAA1549-BRAF融合在毛细胞星形细胞瘤中最高(89%)，差异有统计学意义。KIAA1549-BRAF融合表达与WHO一级胶质瘤差异有统计学意义。结论:总体而言，在22%(9/40)的胶质瘤病例中发现KIAA1549-BRAF基因融合。儿童年龄、毛细胞星形细胞瘤组织学、小脑位置和WHO一级肿瘤与KIAA1549-BRAF基因融合显著相关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neurology and Neurobiology

自引率

0.00%

发文量